1898 related articles for article (PubMed ID: 32436026)
1. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
[TBL] [Abstract][Full Text] [Related]
2. A prognostic nomogram for the cancer-specific survival of patients with upper-tract urothelial carcinoma based on the Surveillance, Epidemiology, and End Results Database.
Li C; Yang J; Xu F; Han D; Zheng S; Kaaya RE; Wang S; Lyu J
BMC Cancer; 2020 Jun; 20(1):534. PubMed ID: 32513124
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
[TBL] [Abstract][Full Text] [Related]
4. A novel prognostic model predicting the long-term cancer-specific survival for patients with hypopharyngeal squamous cell carcinoma.
Tang X; Pang T; Yan WF; Qian WL; Gong YL; Yang ZG
BMC Cancer; 2020 Nov; 20(1):1095. PubMed ID: 33176731
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study.
Yang Z; Bai Y; Liu M; Hu X; Han P
Cancer Med; 2020 Dec; 9(24):9303-9314. PubMed ID: 33063464
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a nomogram for predicting the cancer-specific survival of fibrolamellar hepatocellular carcinoma patients.
Hu J; Wang Y; Deng L; Yu H; Chen K; Bao W; Chen K; Chen G
Updates Surg; 2022 Oct; 74(5):1589-1599. PubMed ID: 35713784
[TBL] [Abstract][Full Text] [Related]
7. A practical nomogram and risk stratification system predicting the cancer-specific survival for patients with early hepatocellular carcinoma.
Yan B; Su BB; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ
Cancer Med; 2021 Jan; 10(2):496-506. PubMed ID: 33280269
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a nomogram for predicting cancer-specific survival in hepatocellular carcinoma patients.
Liu K; Huang G; Chang P; Zhang W; Li T; Dai Z; Lv Y
Sci Rep; 2020 Dec; 10(1):21376. PubMed ID: 33288828
[TBL] [Abstract][Full Text] [Related]
9. Construction of web
Zhan G; Cao P; Peng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1546-1560. PubMed ID: 38432884
[TBL] [Abstract][Full Text] [Related]
10. A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy.
Zhou D; Liu X; Wang X; Yan F; Wang P; Yan H; Jiang Y; Yang Z
BMC Cancer; 2021 Mar; 21(1):246. PubMed ID: 33685417
[TBL] [Abstract][Full Text] [Related]
11. A practical nomogram from the SEER database to predict the prognosis of hepatocellular carcinoma in patients with lymph node metastasis.
Zhang K; Tao C; Wu F; Wu J; Rong W
Ann Palliat Med; 2021 Apr; 10(4):3847-3863. PubMed ID: 33752423
[TBL] [Abstract][Full Text] [Related]
12. Nomogram predicting cancer-specific survival in elderly patients with stages I-III colon cancer.
Zheng P; Lai C; Yang W; Guo J; Xiao S; Chen Z
Scand J Gastroenterol; 2020 Feb; 55(2):202-208. PubMed ID: 32008420
[No Abstract] [Full Text] [Related]
13. Development and Validation of a Nomogram to Predict Cancer-Specific Survival for Middle-Aged Patients With Early-Stage Hepatocellular Carcinoma.
Wen C; Tang J; Luo H
Front Public Health; 2022; 10():848716. PubMed ID: 35296046
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.
Ma Q; Chen Z; Fang Y; Wei X; Wang N; Zhou X; Li S; Ying C
J Endocrinol Invest; 2024 Jan; 47(1):115-129. PubMed ID: 37294407
[TBL] [Abstract][Full Text] [Related]
15. Prognostic nomograms based on log odds of positive lymph nodes for patients with renal cell carcinoma: A retrospective cohort study.
Zhou W; Huang C; Yuan N
Int J Surg; 2018 Dec; 60():28-40. PubMed ID: 30389534
[TBL] [Abstract][Full Text] [Related]
16. Nomogram for predicting cancer-specific survival in undifferentiated pleomorphic sarcoma: A Surveillance, Epidemiology, and End Results -based study.
Xu F; Zhao F; Feng X; Li C; Han D; Zheng S; Liu Y; Lyu J
Cancer Control; 2021; 28():10732748211036775. PubMed ID: 34405711
[TBL] [Abstract][Full Text] [Related]
17. Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
Xu L; Peng ZW; Chen MS; Shi M; Zhang YJ; Guo RP; Lin XJ; Lau WY
J Hepatol; 2015 Jul; 63(1):122-30. PubMed ID: 25725438
[TBL] [Abstract][Full Text] [Related]
18. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
[TBL] [Abstract][Full Text] [Related]
20. A convenient clinical nomogram for predicting the cancer-specific survival of individual patients with small-intestine adenocarcinoma.
Wang N; Yang J; Lyu J; Liu Q; He H; Liu J; Li L; Ren X; Li Z
BMC Cancer; 2020 Jun; 20(1):505. PubMed ID: 32487033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
